Search

Otology training in low- and middle-income countries: a view from within

It is recognised that hearing loss and ear disease are far more common in less affluent parts of the world, and that those countries are often least able to provide treatment; so how can we prioritise care for these patients?...

Hearing implant devices: new expectations during IFOS 2023 ENT World Congress, Dubai

We hear from one of the senior members of the IFOS Executive Board about the aspects of IFOS that he is looking forward to – and, in particular, his focus on implantable hearing devices. From 17 to 21 January 2023,...

Benchmarking for innovation in healthcare ­– an approach from 
Down Under and a gap in the 
National Health Service?

Benchmarking is a process of comparison between the performance characteristics of separate, often competing, organisations intended to enable each participant to improve its own performance [1]. Often, in healthcare, benchmarking is carried out by central government departments or regional agencies...

My experience of implementing remote care during COVID-19

When the COVID-19 pandemic hit, it is safe to say very few audiology services were fully prepared for the challenges it would pose. Gina Angley, Associate Director Adult Amplification Program, Vanderbilt University, tells us about her experience of preparing her...

Practice and pregnancy during COVID-19

The global COVID-19 pandemic has had a significant impact on each of us, both personally and professionally. We have had to adapt the way we live and work and find our ‘new normal’. Francesca Lynch, Senior Paediatric Audiologist at Guy’s...

In conversation with Jayne Fletcher-Brander

What is the process to bring music to a Deaf audience and does it enhance the experience of the hearing viewers? In this interview, Deaf SingSong performer, Jayne Fletcher-Brander takes us through the journey of bringing a signed musical performance...

Wisdom and the cochlear implant clinician

Helen Cullington provides the clinician’s perspective on the challenges faced in building artificial intelligence into cochlear implant clinics. She highlights the importance of including the clinician with their wisdom and experience to help make sense of the patterns of data....

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...